Skip to content

Press

Portfolio-Press Releases
SURGE Therapeutics Receives FDA Clearance of IND Application to Initiate Phase 1/2a Study of Intraoperative Immunotherapy in Bladder Cancer
January 4, 2023 Jan 4, 2023
Portfolio-Press Releases
SURGE Therapeutics Raises $26M Series A Financing to Accelerate Development of Intraoperative Immunotherapy to Improve Survival Outcomes Post-Surgery
October 17, 2022 Oct 17, 2022